Plain-English translation of NCT07784335 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 1 — Testing in a small group (usually 20–80 people) to find a safe dose and watch for side effects.
This is an early-stage safety and dosing study of in healthy volunteers. Researchers want to understand how the body processes this medication—how much gets into your bloodstream, how long it stays there, and how your body eliminates it. This kind of basic research is an essential first step before the medication can be tested in patients with actual health conditions.
Before any new medication can be given to people with medical conditions, scientists need to understand how it moves through a healthy person's body. This trial fills that gap by carefully tracking what happens when volunteers take increasing doses of the treatment, which helps doctors figure out safe and effective dose ranges for future patients.
You would be randomly assigned to receive either the medication or a placebo (inactive treatment) as part of a group of 10 healthy volunteers. Your group would take either one or two daily doses of a specific strength for a defined period while researchers monitor your vital signs, blood work, and how your body processes the medication. The study uses a 'dose-escalation' approach, meaning each new group of volunteers receives a slightly higher dose than the previous group, allowing researchers to safely identify how much of the medication is appropriate.
AI-generated summary from trial data · Aug 27, 2026 · Not medical advice
China